STAAR Surgical Co
NASDAQ:STAA
STAAR Surgical Co
Cash & Cash Equivalents
STAAR Surgical Co
Cash & Cash Equivalents Peer Comparison
Competitive Cash & Cash Equivalents Analysis
Latest Figures & CAGR of Competitors
Company | Cash & Cash Equivalents | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
STAAR Surgical Co
NASDAQ:STAA
|
Cash & Cash Equivalents
$224m
|
CAGR 3-Years
11%
|
CAGR 5-Years
17%
|
CAGR 10-Years
27%
|
|
Cooper Companies Inc
NYSE:COO
|
Cash & Cash Equivalents
$112.4m
|
CAGR 3-Years
2%
|
CAGR 5-Years
1%
|
CAGR 10-Years
3%
|
|
DENTSPLY SIRONA Inc
NASDAQ:XRAY
|
Cash & Cash Equivalents
$291m
|
CAGR 3-Years
-3%
|
CAGR 5-Years
5%
|
CAGR 10-Years
18%
|
|
Align Technology Inc
NASDAQ:ALGN
|
Cash & Cash Equivalents
$865.8m
|
CAGR 3-Years
-9%
|
CAGR 5-Years
8%
|
CAGR 10-Years
17%
|
|
Lantheus Holdings Inc
NASDAQ:LNTH
|
Cash & Cash Equivalents
$718.3m
|
CAGR 3-Years
118%
|
CAGR 5-Years
45%
|
CAGR 10-Years
45%
|
See Also
What is STAAR Surgical Co's Cash & Cash Equivalents?
Cash & Cash Equivalents
224m
USD
Based on the financial report for Mar 29, 2024, STAAR Surgical Co's Cash & Cash Equivalents amounts to 224m USD.
What is STAAR Surgical Co's Cash & Cash Equivalents growth rate?
Cash & Cash Equivalents CAGR 10Y
27%
Over the last year, the Cash & Cash Equivalents growth was 149%. The average annual Cash & Cash Equivalents growth rates for STAAR Surgical Co have been 11% over the past three years , 17% over the past five years , and 27% over the past ten years .